Farzin Haque
Stock Analyst at Jefferies
(3.00)
# 1,291
Out of 5,241 analysts
5
Total ratings
80%
Success rate
64.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Initiates: Buy | $50 | $14.13 | +253.86% | 1 | Mar 30, 2026 | |
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $6.34 | +41.96% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $4.21 | +137.53% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $2.02 | +395.05% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $34.35 | -24.31% | 1 | Nov 10, 2023 |
Vor Biopharma
Mar 30, 2026
Initiates: Buy
Price Target: $50
Current: $14.13
Upside: +253.86%
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $6.34
Upside: +41.96%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.21
Upside: +137.53%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $34.35
Upside: -24.31%